Alvin L.

Alvin L. is the Co-Founder and CEO of HuidaGene Therapeutics, a global biotechnology company focusing on CRISPR-based gene-editing tools and therapies. With extensive experience in the biotech industry, serving on multiple advisory boards and in various leadership roles, Alvin L. has contributed significantly to the development of gene therapies for ocular diseases and rare genetic disorders. With a background in neurobiology and neurosciences, Alvin L. is recognized for their strategic approach to global drug development and clinical operations.